Broader investment controls ‘would damage US biosciences’

Bioindustry lobby group says broadening definitions of personal data would hurt “critical” foreign investment

The Biotechnology Innovation Organization, an industry lobby group, has written to the Treasury to caution against expanding the scope of the department’s restrictions on foreign investment.

The letter, dated 17 October and signed by the president of the group’s lobbying unit, Tom DiLenge, asked the Treasury to reconsider planned new rules that it said “miss the mark by unnecessarily expanding the scope of transactions subject to review”.